OrbiMed Royalty & Credit Opportunities V, LP updates its Form D — $1.24B sold

Fund raise update · Private equity / buyout · Raising · NEW YORK, NY · Form D/A filed 2025-05-06 · all Orbimed Royalty vehicles · Follow Orbimed Royalty →

$100M+ sold3(c)(7) — qualified purchasers

How this compares

$1.75B is larger than 99% of the 3,018 private equity / buyout fund launches with a stated size in the last two years; the median is $5.1M.
Among 1,694 fund launches filed from NY in the same window it is larger than 99%; the NY median is $5M.
Across 493 private equity / buyout sponsors with more than one launch on EDGAR, the median gap between consecutive funds is 5 months.
This is the sponsor's 2nd fund launch on EDGAR; the previous one, OrbiMed Royalty & Credit Opportunities V, LP, was filed 6 months earlier at $1.75B.

Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.

Raise progress

Filed	Form	Sold	Investors	Change
2024-11-14	D	$0	0
2025-05-06	D/A	$1.24B	52	+$1.24B

Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.

Orbimed Royalty on EDGAR

Earlier and related filings by the same issuer and sponsor. All Orbimed Royalty vehicles →

100

OrbiMed Royalty & Credit Opportunities V, LP files a $1.75B private equity / buyout fund

New fund · Private equity / buyout · Pre-first close · Offering $1.75B · NEW YORK, NY · filed 2024-11-14

3(c)(7) — qualified purchasersPre-first closeFirst filing by this entity

People on the filing

Carl L. Gordon	Executive Officer
N/A OrbiMed ROF V, LP	Executive Officer
Matthew S. Rizzo	Executive Officer
N/A OrbiMed Advisors LLC	Executive Officer
David P. Bonita	Executive Officer
Geoffrey C. Hsu	Executive Officer
C. Scotland Stevens	Executive Officer
N/A OrbiMed ROF V LLC	Executive Officer
W. Carter Neild	Executive Officer
Sven H. Borho	Executive Officer
Peter A. Thompson	Executive Officer

[email protected] · observed Work emails for the people on the filing, where the firm publishes or patterns them, labelled by confidence — subscribers

Signed by W. Carter Neild, Member of OrbiMed Advisors.

Placement agents / sales compensation: J.P. Morgan Securities LLC

Why now — by persona

Relevant to: Fund audit & tax, Fund administrator.

Filing contact

The issuer's phone number and address from the filing are shown to subscribers. See plans.